Murphy Canyon Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, and adjacent businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in San Diego, California.
IPO Year: 2022
Exchange: NASDAQ
Website: https://murphycanyonac.com
| Date | Price Target | Rating | Analyst |
|---|
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
Fastest customizable press release news feed in the world
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose acquisition company (NASDAQ:MURF) ("MURF"), announced today the completion of the previously announced business combination (the "Transaction"). Conduit expects to commence trading on September 25, 2023, under ticker symbol "CDT" for its common stock on The Nasdaq Global Market and ticker symbol "CDTTW" for its warrants on The Nasdaq Capital Market.At the debut of trading, there will be a pro forma enterpris
SAN DIEGO, CA / ACCESSWIRE / September 20, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) ("MURF" or "Murphy Canyon"), a special purpose acquisition company, announced today that at a special meeting of the MURF stockholders (the "Special Meeting") held today, MURF's stockholders voted in favor of the proposed business combination (the "Business Combination") with Conduit Pharmaceuticals Limited ("Conduit") and the related proposals. As a result, the completion of the Business Combination is expected to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions. Following the completion of the Business Combination, the newly combined company wil
SAN DIEGO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (NASDAQ:SQFT, SQFTP))) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors (the "Board") has established a Special Committee of the Board (the "Special Committee") to explore potential strategic alternatives focusing on maximizing stockholder value. The Special Committee is comprised solely of independent directors and is charged with exploring potential strategic alternatives, including, without limitation, a business combination involving the Company, a sale of all or part of the Company's assets, joint venture arrangements and/or
SAN DIEGO, CA / ACCESSWIRE / September 7, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) or ("Murphy Canyon") announced today that its special meeting of stockholders (the "Meeting"), which was originally scheduled for September 13, 2023, has been postponed to 10:00 a.m., Eastern Time, on Wednesday, September 20, 2023. At the Meeting, stockholders of Murphy Canyon will be asked to vote on proposals to approve, among other things, its initial business combination with Conduit Pharmaceuticals Limited, a Cayman Islands exempted company ("Conduit"), which Murphy Canyon previously announced on November 8, 2022 (the "Business Combination").As a result of this change, the Meeting will now be
Special meeting of Murphy Canyon stockholders to vote on the proposed business combination scheduled for September 7, 2023Conduit is a disease agnostic life science company providing an efficient model for compound development led by a highly experienced team of pharmaceutical executivesMurphy Canyon and Conduit entered into a definitive business combination agreement dated November 8, 2022, as amended (the "Business Combination Agreement")Combined company expected to be named Conduit Pharmaceuticals Inc. and listed on Nasdaq in the third quarter of 2023 under the symbols "CDT" and "CDTTW"SAN DIEGO, CA / ACCESSWIRE / August 16, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) or ("Murphy
SAN DIEGO, CA / ACCESSWIRE / August 14, 2023 / Presidio Property Trust, Inc. (NASDAQ:SQFT)(NASDAQ:SQFTP) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its quarter ended June 30, 2023.Quarter Ended June 30, 2023, Financial ResultsNet loss attributable to the Company's common stockholders for the three months ended June 30, 2023, was approximately $1,831,889, or $(0.15) per basic and diluted share, compared to a net loss of approximately $830,212, or $(0.07) per basic and diluted share for the three months ended June 30, 2022. The change in net income attributable to the Company's common stockholders was a result of: •An
SAN DIEGO, CA / ACCESSWIRE / July 11, 2023 / Presidio Property Trust, Inc. ("Presidio" or the "Company") (NASDAQ:SQFT)(NASDAQ:SQFTP)(NASDAQ:SQFTW), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock (the "Series D Preferred Stock") for the month of July 2023, August 2023 and September 2023.In accordance with the terms of the Series D Preferred Stock, the July 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on August 15, 2023, to shareholders of record of Series D Pr
Presidio Property Trust pays cash dividend of $0.023 per shareSAN DIEGO, CA / ACCESSWIRE / July 3, 2023 / (NASDAQ:SQFT)(NASDAQ:SQFTP) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that on June 30, 2023 the Company paid its third consecutive quarterly common stock dividend increase since September 30, 2023. The common stock dividend of $0.023 per share was paid on Friday, June 30, 2023 to all stockholders of record as of the close of business on June 27, 2023.About Presidio Property TrustPresidio is an internally managed, diversified REIT with holdings in model home properties which are tr
SAN DIEGO, CA / ACCESSWIRE / June 27, 2023 / (NASDAQ:SQFT, SQFTP))) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT") announced that in June 2023, through subsidiary and affiliate entities, it acquired 7 newly constructed single-family model home properties located in greater Dallas/Ft. Worth, Texas. These 7 homes were purchased for a total of approximately $4.2 million, with mortgage notes payable of approximately $2.9 million, and approximately $1.3 million in cash. They are then leased back to the homebuilders on a triple-net basis."Texas has been a market we remain very active in and has provided us with
Board of Directors approves cash dividend of $0.023 per shareSAN DIEGO, CA / ACCESSWIRE / June 16, 2023 / (NASDAQ:SQFT, SQFTP))) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors has authorized a cash dividend of $0.023 per share on its Series A Common Stock for the second quarter of 2023.The dividend will be payable on June 30, 2023, to all stockholders of record as of the close of business on June 27, 2023.About Presidio Property TrustPresidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuil
S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
424B3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
EFFECT - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
S-1/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
10-Q/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
NT 10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
S-1 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
8-K/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
Live finance-specific insights
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., a special purpose acquisition company (NASDAQ:MURF) ("MURF"), announced today the completion of the previously announced business combination (the "Transaction"). Conduit expects to commence trading on September 25, 2023, under ticker symbol "CDT" for its common stock on The Nasdaq Global Market and ticker symbol "CDTTW" for its warrants on The Nasdaq Capital Market.At the debut of trading, there will be a pro forma enterpris
SAN DIEGO, CA / ACCESSWIRE / September 20, 2023 / Murphy Canyon Acquisition Corp. (NASDAQ:MURF) ("MURF" or "Murphy Canyon"), a special purpose acquisition company, announced today that at a special meeting of the MURF stockholders (the "Special Meeting") held today, MURF's stockholders voted in favor of the proposed business combination (the "Business Combination") with Conduit Pharmaceuticals Limited ("Conduit") and the related proposals. As a result, the completion of the Business Combination is expected to occur as soon as practicable, subject to the satisfaction or waiver of remaining closing conditions. Following the completion of the Business Combination, the newly combined company wil
SAN DIEGO, CA / ACCESSWIRE / August 14, 2023 / Presidio Property Trust, Inc. (NASDAQ:SQFT)(NASDAQ:SQFTP) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its quarter ended June 30, 2023.Quarter Ended June 30, 2023, Financial ResultsNet loss attributable to the Company's common stockholders for the three months ended June 30, 2023, was approximately $1,831,889, or $(0.15) per basic and diluted share, compared to a net loss of approximately $830,212, or $(0.07) per basic and diluted share for the three months ended June 30, 2022. The change in net income attributable to the Company's common stockholders was a result of: •An
SAN DIEGO, CA / ACCESSWIRE / July 11, 2023 / Presidio Property Trust, Inc. ("Presidio" or the "Company") (NASDAQ:SQFT)(NASDAQ:SQFTP)(NASDAQ:SQFTW), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock (the "Series D Preferred Stock") for the month of July 2023, August 2023 and September 2023.In accordance with the terms of the Series D Preferred Stock, the July 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on August 15, 2023, to shareholders of record of Series D Pr
Presidio Property Trust pays cash dividend of $0.023 per shareSAN DIEGO, CA / ACCESSWIRE / July 3, 2023 / (NASDAQ:SQFT)(NASDAQ:SQFTP) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that on June 30, 2023 the Company paid its third consecutive quarterly common stock dividend increase since September 30, 2023. The common stock dividend of $0.023 per share was paid on Friday, June 30, 2023 to all stockholders of record as of the close of business on June 27, 2023.About Presidio Property TrustPresidio is an internally managed, diversified REIT with holdings in model home properties which are tr
Board of Directors approves cash dividend of $0.023 per shareSAN DIEGO, CA / ACCESSWIRE / June 16, 2023 / (NASDAQ:SQFT, SQFTP))) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors has authorized a cash dividend of $0.023 per share on its Series A Common Stock for the second quarter of 2023.The dividend will be payable on June 30, 2023, to all stockholders of record as of the close of business on June 27, 2023.About Presidio Property TrustPresidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuil
SAN DIEGO, CA / ACCESSWIRE / May 15, 2023 / Presidio Property Trust, Inc. (NASDAQ:SQFT, SQFTP))) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its quarter ended March 31, 2022.Quarter Ended March 31, 2023, Financial ResultsNet loss attributable to the Company's common stockholders for the three months ended March 31, 2023, was approximately $(1,530,988), or $(0.13) per basic and diluted share, compared to a net income of approximately $(3,824,053), or $(0.32) per basic and diluted share for the three months ended March 31, 2022. The change in net income attributable to the Company's common stockholders was a result of:
SAN DIEGO, CA / ACCESSWIRE / April 13, 2023 / (NASDAQ:SQFT)(NASDAQ:SQFTP)(NASDAQ:SQFTW) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock (the "Series D Preferred Stock") for the month of April 2023, May 2023 and June 2023.In accordance with the terms of the Series D Preferred Stock, the April 2023 Series D dividend will be payable in cash in the amount of $0.19531 per share on May 15, 2023, to shareholders of record of Series D Preferred
SAN DIEGO, CA / ACCESSWIRE / March 28, 2023 / Presidio Property Trust, Inc. (NASDAQ:SQFT)(NASDAQ:SQFTP) (the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today reported earnings for its year ended December 31, 2022."We are pleased to report on our 2022 earnings and company activity," said Jack Heilbron, Chief Executive Officer of Presidio. "2022 was a challenging year in the real estate markets, but our diversified nature helped us take advantage of homebuilder interest in our model home division. We also saw solid leasing activity on the commercial property side. Additionally, in 2022, we reached an agreement on the business combination of Murphy Can
SAN DIEGO, CA / ACCESSWIRE / March 20, 2023 / (NASDAQ:SQFT, SQFTP))) Presidio Property Trust, Inc. ("Presidio" or the "Company"), an internally managed, diversified real estate investment trust ("REIT"), today announced that its press release issued under the headline "Presidio Property Trust Declares First-Quarter 2023 Dividend" on March 20, 2023, was changed to correct the record date for the dividend on its Series A Common Stock for the first quarter of 2023. The dividend amount and payment date have not changed. The dividend will be payable on March 31, 2023, to all stockholders of record as of the close of business on March 30, 2023, not stockholders of record on March 27, 2023 as previ
This live feed shows all institutional transactions in real time.
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13D/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13D - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
SC 13D - Murphy Canyon Acquisition Corp. (0001896212) (Subject)
SC 13G/A - Murphy Canyon Acquisition Corp. (0001896212) (Subject)
SC 13G - Murphy Canyon Acquisition Corp. (0001896212) (Subject)